Back to Trades
GORMAN KEVIN CHARLES
DirectorCIK 0001201096
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 3
- Companies
- 2
- Active
- 2025–2026
Across 7 filings between 2025–2026, GORMAN KEVIN CHARLES, Director, has disclosed $83.2M in transactions — spread across 2 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $51.4M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Jul 8 | XNCR Xencor Inc | GORMAN KEVIN CHARLES | Director | Grant | $251.4K |
| Jun 17 | XNCR Xencor Inc | GORMAN KEVIN CHARLES | Director | Sell | $92.7K |
| May 29 | NBIX NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Director | Award | $817.8K |
| May 21 | NBIX NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Director | Sell | $37.8M |
| Feb 17 | NBIX NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Director | Grant | $5.0M |
| Feb 3 | NBIX NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Director | Exercise | $387.1K |
| Aug 11 | NBIX NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Director | Sell | $13.4M |
7 filings